唐南珊

Dr. Nancy Chang, joined OrbiMed in 2007 as a Managing Director, Asia. Dr. Chang was the Co-Founder, CEO and Chairman of Tanox, Inc. She brings over 25 years of excellence in pioneering scientific research and entrepreneurial success to OrbiMed.

Dr. Chang built Tanox from an idea to a substantial publicly-traded company which was acquired by Genentech in August 2007 for $919 Million. Tanox’s initial public offering in 2000 was the second largest IPO ever for a biotechnology company at that time. During her career, Dr. Chang has received numerous awards for her leadership, including the Most Respected Woman in Biotechnology (MedAd News, 2005), Global Business Achievement Hall of Fame Governor’s Award (2005), Texas Science Hall of Fame (2001), and Houston Entrepreneur of the Year (2000).

Dr. Chang serves on the Boards of Directors of the Federal Reserve Bank in Houston, Charles River Laboratories, and she is also a member of the Board of Visitors at M. D. Anderson Cancer Center. Before launching Tanox, Dr. Chang served as Director of Research at Centocor, Inc. She received her Ph.D. in Biological Chemistry from Harvard University.